SPDR S&P MIDCAP 400 ETF ETF Prediction and Forecast [MDY]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 24 Dec 2025, 04:30 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for SPDR S&P MIDCAP 400 ETF ETF Prediction and Forecast [MDY]](https://i.ytimg.com/vi/sMXx-GaD0ck/hqdefault.jpg)
AI-generated source summary
The SPDR S&P Midcap 400 ETF (MDY) shows mixed signals, with short-term buy signals and a generally positive trend, but also recent selling pressure and headline-driven volatility. The ETF has experienced low daily movements and low risk, with a buy signal from a pivot bottom 4 days ago. A potential buy opportunity exists at current levels, with an expected opening price of $614.27 on Wednesday. The trailing stop-loss is set at $581.55. The ETF's performance over the last week has been a gain of 0.73%, and over the last two weeks, it gained 1.36%. Over the last 12 months, it gained 9.44%, with a price range of $581.55 to $622.79. Technical indicators like MACD, pivots, and moving averages suggest a bullish outlook for short-term trading, while longer-term indicators also point to a buy.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.